- Home
- YMAB vs SWBI Comparison
YMAB vs SWBI Comparison
Compare YMAB & SWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- SWBI
- Stock Information
- Founded
- YMAB 2015
- SWBI 1852
- Country
- YMAB United States
- SWBI United States
- Employees
- YMAB N/A
- SWBI N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- SWBI Ordnance And Accessories
- Sector
- YMAB Health Care
- SWBI Industrials
- Exchange
- YMAB Nasdaq
- SWBI Nasdaq
- Market Cap
- YMAB 386.7M
- SWBI 429.0M
- IPO Year
- YMAB 2018
- SWBI N/A
- Fundamental
- Price
- YMAB $8.61
- SWBI $9.42
- Analyst Decision
- YMAB Buy
- SWBI Buy
- Analyst Count
- YMAB 10
- SWBI 2
- Target Price
- YMAB $13.91
- SWBI $12.00
- AVG Volume (30 Days)
- YMAB 874.6K
- SWBI 1.2M
- Earning Date
- YMAB 11-07-2025
- SWBI 09-04-2025
- Dividend Yield
- YMAB N/A
- SWBI 5.52%
- EPS Growth
- YMAB N/A
- SWBI N/A
- EPS
- YMAB N/A
- SWBI 0.26
- Revenue
- YMAB $85,385,000.00
- SWBI $471,404,000.00
- Revenue This Year
- YMAB N/A
- SWBI N/A
- Revenue Next Year
- YMAB $13.97
- SWBI $2.44
- P/E Ratio
- YMAB N/A
- SWBI $35.81
- Revenue Growth
- YMAB N/A
- SWBI N/A
- 52 Week Low
- YMAB $3.55
- SWBI $7.73
- 52 Week High
- YMAB $16.11
- SWBI $14.20
- Technical
- Relative Strength Index (RSI)
- YMAB 81.21
- SWBI 72.37
- Support Level
- YMAB $8.50
- SWBI $9.14
- Resistance Level
- YMAB $8.56
- SWBI $9.67
- Average True Range (ATR)
- YMAB 0.02
- SWBI 0.39
- MACD
- YMAB -0.12
- SWBI 0.12
- Stochastic Oscillator
- YMAB 100.00
- SWBI 80.11
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About SWBI Smith & Wesson Brands Inc.
Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.